Goldman Sachs Group Inc Roivant Sciences Ltd. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 5,392,375 shares of ROIV stock, worth $67.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,392,375
Previous 4,201,335 28.35%
Holding current value
$67.3 Million
Previous $44.4 Million 40.13%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$10.17 - $12.5 $12.1 Million - $14.9 Million
1,191,040 Added 28.35%
5,392,375 $62.2 Million
Q2 2024

Aug 13, 2024
BUY
$10.36 - $11.74 $28 Million - $31.7 Million
2,702,419 Added 180.29%
4,201,335 $44.4 Million
Q1 2024

May 15, 2024
BUY
$9.87 - $11.8 $10.7 Million - $12.8 Million
1,085,821 Added 262.85%
1,498,916 $15.8 Million
Q4 2023

Feb 13, 2024
BUY
$8.38 - $11.58 $1.43 Million - $1.98 Million
170,966 Added 70.61%
413,095 $4.64 Million
Q3 2023

May 14, 2024
SELL
$9.76 - $13.19 $1.67 Million - $2.26 Million
-170,966 Reduced 41.39%
242,129 $2.83 Million
Q3 2023

Nov 14, 2023
BUY
$9.76 - $13.19 $1.4 Million - $1.89 Million
142,981 Added 144.21%
242,129 $2.83 Million
Q2 2023

May 14, 2024
SELL
$7.09 - $10.08 $11.9 Million - $16.9 Million
-1,676,043 Reduced 94.41%
99,148 $999,000
Q2 2023

Aug 14, 2023
SELL
$7.09 - $10.08 $11.9 Million - $16.9 Million
-1,676,043 Reduced 94.41%
99,148 $999,000
Q1 2023

May 14, 2024
BUY
$6.92 - $9.98 $8.68 Million - $12.5 Million
1,253,849 Added 240.5%
1,775,191 $13.1 Million
Q1 2023

May 11, 2023
BUY
$6.92 - $9.98 $8.68 Million - $12.5 Million
1,253,849 Added 240.5%
1,775,191 $13.1 Million
Q4 2022

May 14, 2024
BUY
$3.36 - $7.99 $1.08 Million - $2.58 Million
322,742 Added 162.51%
521,342 $4.17 Million
Q4 2022

Feb 13, 2023
BUY
$3.36 - $7.99 $1.08 Million - $2.58 Million
322,742 Added 162.51%
521,342 $4.17 Million
Q3 2022

May 14, 2024
SELL
$0.51 - $4.84 $1,366 - $12,971
-2,680 Reduced 1.33%
198,600 $639,000
Q3 2022

Nov 10, 2022
SELL
$0.51 - $4.84 $1,366 - $12,971
-2,680 Reduced 1.33%
198,600 $639,000
Q2 2022

May 14, 2024
SELL
$2.81 - $4.84 $595,200 - $1.03 Million
-211,815 Reduced 51.28%
201,280 $819,000
Q2 2022

Aug 15, 2022
BUY
$2.81 - $4.84 $508,860 - $876,470
181,089 Added 896.88%
201,280 $819,000
Q1 2022

May 16, 2022
BUY
$4.74 - $9.91 $95,705 - $200,092
20,191 New
20,191 $100,000

Others Institutions Holding ROIV

# of Institutions
311
Shares Held
508M
Call Options Held
1.26M
Put Options Held
2.52M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.79B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email